DiaMedica Therapeutics FY 2024 GAAP EPS $(0.60) Misses $(0.59) Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings MissesNews
DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.59) by 1.69 percent.
DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.60) per share which missed the analyst consensus estimate of $(0.59) by 1.69 percent.